Stoke Therapeutics Inc (STOK)
11.82
-0.12
(-1.01%)
USD |
NASDAQ |
May 08, 11:02
Stoke Therapeutics Market Cap: 616.06M for May 8, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 07, 2024 | 622.31M |
| May 06, 2024 | 618.66M |
| May 03, 2024 | 626.48M |
| May 02, 2024 | 609.28M |
| May 01, 2024 | 602.51M |
| April 30, 2024 | 574.88M |
| April 29, 2024 | 618.14M |
| April 26, 2024 | 646.78M |
| April 25, 2024 | 609.25M |
| April 24, 2024 | 607.69M |
| April 23, 2024 | 586.32M |
| April 22, 2024 | 586.32M |
| April 19, 2024 | 628.02M |
| April 18, 2024 | 607.17M |
| April 17, 2024 | 610.82M |
| April 16, 2024 | 648.86M |
| April 15, 2024 | 636.35M |
| April 12, 2024 | 665.54M |
| April 11, 2024 | 703.59M |
| April 10, 2024 | 665.02M |
| April 09, 2024 | 669.71M |
| April 08, 2024 | 677.53M |
| April 05, 2024 | 651.87M |
| April 04, 2024 | 631.13M |
| April 03, 2024 | 664.58M |
| Date | Value |
|---|---|
| April 02, 2024 | 678.32M |
| April 01, 2024 | 627.26M |
| March 28, 2024 | 625.10M |
| March 27, 2024 | 656.12M |
| March 26, 2024 | 476.47M |
| March 25, 2024 | 300.97M |
| March 22, 2024 | 291.71M |
| March 21, 2024 | 277.36M |
| March 20, 2024 | 277.36M |
| March 19, 2024 | 268.56M |
| March 18, 2024 | 281.53M |
| March 15, 2024 | 295.88M |
| March 14, 2024 | 297.55M |
| March 13, 2024 | 314.54M |
| March 12, 2024 | 304.44M |
| March 11, 2024 | 331.53M |
| March 08, 2024 | 347.60M |
| March 07, 2024 | 351.27M |
| March 06, 2024 | 365.97M |
| March 05, 2024 | 327.40M |
| March 04, 2024 | 314.77M |
| March 01, 2024 | 350.36M |
| February 29, 2024 | 355.41M |
| February 28, 2024 | 365.51M |
| February 27, 2024 | 375.15M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
149.27M
Minimum
Oct 27 2023
2.553B
Maximum
Jan 19 2021
793.90M
Average
744.53M
Median
Mar 19 2020
Market Cap Benchmarks
| NeuBase Therapeutics Inc | 1.492M |
| iBio Inc | 6.829M |
| Actinium Pharmaceuticals Inc | 255.54M |
| Lixte Biotechnology Holdings Inc | 6.523M |
| Fate Therapeutics Inc | 375.61M |
Market Cap Related Metrics
| PS Ratio | 67.68 |
| Price to Book Value | 4.390 |
| Price | 11.82 |
| Earnings Yield | -20.39% |